| Mr Edward Savoy, RPH | |
|
601 10th Ave S, Great Falls, MT 59405-4048 | |
| (406) 268-1499 | |
| Not Available |
| Full Name | Mr Edward Savoy |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 601 10th Ave S, Great Falls, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053477125 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 3426 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Edward Savoy, RPH 69 Cherokee Dr, Great Falls, MT 59404-6413 Ph: (406) 268-1469 | Mr Edward Savoy, RPH 601 10th Ave S, Great Falls, MT 59405-4048 Ph: (406) 268-1499 |
News Archive
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) suggests that lifestyle advice for people with diabetes should be no different from that for the general public, although those with diabetes may benefit more from that same advice.
For years brain scientists have puzzled over the shadowy role played by the molecule putrescine, which always seems to be present in the brain following an epileptic seizure, but without a clear indication whether it was there to exacerbate brain damage that follows a seizure or protect the brain from it. A new Brown University study unmasks the molecule as squarely on the side of good: It seems to protect against seizures hours later.
Thrasos Therapeutics announced that it has completed a $35 Million (U.S.) financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury (AKI).
With 10 million people a year projected to die from antibiotic-resistant infections by 2050, it's important that all partners, including the pharmaceutical industry, step up and work together to tackle this issue.
Mylan Inc. has confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Hoffmann-La Roche Inc. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Capecitabine Tablets, 150 mg and 500 mg, the generic version of Xeloda Tablets, a chemotherapy treatment for breast and colorectal cancer.
› Verified 2 days ago
Dr. Anjanet Rahn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 15th Ave S, Great Falls, MT 59405 Phone: 406-771-3065 | |
Jo Lynn Hickey, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 701 Smelter Ave Ne, Great Falls, MT 59404 Phone: 406-761-1456 Fax: 406-761-4536 | |
Leeann S Jovick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 10th Ave S, Great Falls, MT 59405 Phone: 406-453-1318 Fax: 406-454-3982 | |
Darci Barsotti, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5320 10th Ave S, Great Falls, MT 59405 Phone: 406-770-6070 | |
Jessica Lynn Powell, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1414 3rd St Nw, Great Falls, MT 59404 Phone: 406-761-8420 Fax: 406-727-0336 | |
Matthew Mills, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 13th Ave S, Great Falls, MT 59405 Phone: 406-315-1989 Fax: 406-315-1988 | |
Terrence Yenchek, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2301 10th Ave S, Great Falls, MT 59405 Phone: 406-727-1376 Fax: 406-727-2964 |